A summary of pre-clinical and clinical trial data, including mechanism of action, pharmacokinetics and tumor responses in investigations of PTC596, a novel molecule designed to reduce survival of cancer stem cells (CSCs) feature in our poster from the 2019 American Association of Cancer Research (AACR) Annual Meeting, held in Atlanta
AACR 2019 poster: PTC596 combination therapy for sarcoma
GL-CORP-0207 | June 2021
The content you are trying to access is not currently available.
We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.